{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:44:12Z","timestamp":1778589852459,"version":"3.51.4"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.pharmthera.2011.10.001","type":"journal-article","created":{"date-parts":[[2011,10,15]],"date-time":"2011-10-15T13:26:12Z","timestamp":1318685172000},"page":"133-141","source":"Crossref","is-referenced-by-count":9,"title":["Genetic approaches to a better understanding of bipolar disorder"],"prefix":"10.1016","volume":"133","author":[{"given":"James","family":"Offord","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2011.10.001_bb0005","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1176\/appi.ajp.2010.09071011","article-title":"Major depressive disorder with subthreshold bipolarity in the national comorbidity survey replication","volume":"167","author":"Angst","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0193-953X(03)00036-4","article-title":"Gender differences in bipolar disorder","volume":"26","author":"Arnold","year":"2003","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1601-183X.2010.00657.x","article-title":"ZNF804A may be associated with executive control of attention","volume":"10","author":"Balog","year":"2011","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.mp.4002012","article-title":"A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder","volume":"13","author":"Baum","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0025","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/archgenpsychiatry.2010.96","article-title":"Genetic variation in CACNA1C affects brain circuitries related to mental illness","volume":"67","author":"Bigos","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0030","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nrg932","article-title":"Classical twin studies and beyond","volume":"3","author":"Boomsma","year":"2002","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1399-5618.2007.00500.x","article-title":"Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials","volume":"10","author":"Calabrese","year":"2008","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0040","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archpsyc.56.2.162","article-title":"Heritability estimates for psychotic disorders: The Maudsley Twin Psychosis Series","volume":"56","author":"Cardno","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0045","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/ajmg.b.31122","article-title":"L-type calcium channels and psychiatric disorders: A brief review","volume":"153B","author":"Casamassima","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ajmg.b.30962","article-title":"Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder","volume":"153B","author":"Casamassima","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0055","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/01.chi.0000159948.75136.0d","article-title":"Reduced amygdalar gray matter volume in familial pediatric bipolar disorder","volume":"44","author":"Chang","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00008877-199711000-00019","article-title":"Assessment of the antidepressant-like effects of L-type voltage-dependent channel modulators","volume":"8","author":"Cohen","year":"1997","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0065","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.1375392","article-title":"Cystic fibrosis: molecular biology and therapeutic implications","volume":"256","author":"Collins","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0070","first-page":"10","article-title":"A framework for interpreting genome-wide association studies of psychiatric disorders","volume":"14","author":"Committee, P. G. C. S.","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0075","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nature02168","article-title":"The International HapMap Project","volume":"426","author":"Consortium, T. I. H","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0080","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","article-title":"Common polygenic variation contributes to risk of schizophrenia and bipolar disorder","volume":"460","author":"Consortium, T. I. S","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0085","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","author":"Consortium, T. W. T. C. C","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0090","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1017\/S0033291709991723","article-title":"Genome-wide association studies: A primer","volume":"40","author":"Corvin","year":"2010","journal-title":"Psychol Med"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0028-3908(89)90097-X","article-title":"Dihydropyridine calcium channel antagonists as antidepressant drugs in mice and rats","volume":"28","author":"Czyrak","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0100","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2010.06.019","article-title":"Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans","volume":"68","author":"Dao","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0105","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0006-3223(95)00293-6","article-title":"Linkage analysis of families with bipolar illness and chromosome 18 markers","volume":"39","author":"De bruyn","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0110","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1055\/s-0031-1275275","article-title":"A systems approach to the biology of mood disorders through network analysis of candidate genes","volume":"44","author":"Detera-Wadleigh","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0115","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archgenpsychiatry.2010.94","article-title":"Brain function in carriers of a genome-wide supported bipolar disorder variant","volume":"67","author":"Erk","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0120","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.neuroimage.2010.10.012","article-title":"Cognitive state and connectivity effects of the genome-wide significant psychosis variant in ZNF804A","volume":"54","author":"Esslinger","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0125","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/ng.209","article-title":"Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder","volume":"40","author":"Ferreira","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0130","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.biopsych.2010.05.037","article-title":"Genetic variation in CACNA1C, a gene associated with bipolar disorder, influences brainstem rather than gray matter volume in healthy individuals","volume":"68","author":"Franke","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0135","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.4088\/JCP.v66n1106","article-title":"Typical and atypical antipsychotics in bipolar depression","volume":"66","author":"Gao","year":"2005","journal-title":"The Journal of clinical psychiatry,"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0140","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.bp.107.048504","article-title":"Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials","volume":"194","author":"Geddes","year":"2009","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0145","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1176\/appi.ajp.161.9.1537","article-title":"Antidepressants for bipolar depression: A systematic review of randomized, controlled trials","volume":"161","author":"Gijsman","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0150","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMp0806284","article-title":"Common genetic variation and human traits","volume":"360","author":"Goldstein","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0155","series-title":"Manic-depressive illness","author":"Goodwin","year":"2007"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0160","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/mp.2009.49","article-title":"The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia","volume":"15","author":"Green","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0165","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1017\/S1092852900013912","article-title":"Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: Fact or overinterpretation?","volume":"13","author":"Grunze","year":"2008","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0170","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nbt0409-349","article-title":"SNP imputation in association studies","volume":"27","author":"Halperin","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0180","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0185","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/ajmg.b.31123","article-title":"The impact of a genome-wide supported psychosis variant in the ZNF804A gene on memory function in schizophrenia","volume":"153B","author":"Hashimoto","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0190","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/ajmg.b.30941","article-title":"Preliminary genome-wide association study of bipolar disorder in the Japanese population","volume":"150B","author":"Hattori","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0195","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1083\/jcb.200806112","article-title":"AnkyrinG is required for maintenance of the axon initial segment and neuronal polarity","volume":"183","author":"Hedstrom","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0200","first-page":"S85","article-title":"Bipolar disorder: Costs and comorbidity","volume":"11","author":"Hirschfeld","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ajhg.2009.05.011","article-title":"Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder","volume":"85","author":"Holmans","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0210","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.biopsych.2010.07.010","article-title":"Genome-wide association study of schizophrenia in a Japanese population","volume":"69","author":"Ikeda","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0215","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1086\/521690","article-title":"The first genomewide interaction and locus-heterogeneity linkage scan in bipolar affective disorder: Strong evidence of epistatic effects between loci on chromosomes 2q and 6q","volume":"81","author":"Jamra","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0220","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1399-5618.2004.00180.x","article-title":"Gender differences in bipolar disorder: age of onset, course, comorbidity, and symptom presentation","volume":"7","author":"Kawa","year":"2005","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0230","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1176\/appi.ajp.161.10.1814","article-title":"High concordance of bipolar I disorder in a nationwide sample of twins","volume":"161","author":"Kieseppa","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0235","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nrg1636","article-title":"The art and design of genetic screens: Mouse","volume":"6","author":"Kile","year":"2005","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0240","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/BF00219345","article-title":"Genetic linkage analysis of bipolar affective disorder in an Old Order Amish pedigree","volume":"88","author":"Law","year":"1992","journal-title":"Hum Genet"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0245","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1038\/npp.2010.102","article-title":"A schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypes","volume":"35","author":"Lencz","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0250","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0920-9964(99)00063-8","article-title":"Cortical gray matter deficit in patients with bipolar disorder","volume":"40","author":"Lim","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0255","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/mp.2009.107","article-title":"Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder","volume":"16","author":"Liu","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0260","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.biopsych.2003.10.017","article-title":"Frontal lobe gray matter density decreases in bipolar I disorder","volume":"55","author":"Lyoo","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0265","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra0905980","article-title":"Genomewide association studies and assessment of the risk of disease","volume":"363","author":"Manolio","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0270","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archpsyc.60.5.497","article-title":"The heritability of bipolar affective disorder and the genetic relationship to unipolar depression","volume":"60","author":"McGuffin","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0275","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0447.2005.00523.x","article-title":"Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder","volume":"111","author":"Muzina","year":"2005","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0280","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/mp.2009.69","article-title":"CACNA1C (rs1006737) is associated with schizophrenia","volume":"15","author":"Nyegaard","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0285","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/ng.201","article-title":"Identification of loci associated with schizophrenia by genome-wide association and follow-up","volume":"40","author":"O'Donovan","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0290","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biopsych.2006.07.011","article-title":"Affective neural circuitry during facial emotion processing in pediatric bipolar disorder","volume":"62","author":"Pavuluri","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0295","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0920-9964(99)00112-7","article-title":"Structural and functional brain changes in bipolar disorder: A selective review","volume":"39","author":"Pearlson","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0300","first-page":"S271","article-title":"Misdiagnosis of bipolar disorder","volume":"11","author":"Perlis","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0305","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1038\/npp.2010.122","article-title":"Transition to mania during treatment of bipolar depression","volume":"35","author":"Perlis","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0310","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4088\/JCP.v67n0401","article-title":"Atypical antipsychotics in the treatment of mania: A meta-analysis of randomized, placebo-controlled trials","volume":"67","author":"Perlis","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0315","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.eurpsy.2010.10.004","article-title":"Initial evidence for the role of CACNA1C on subcortical brain morphology in patients with bipolar disorder","volume":"26","author":"Perrier","year":"2011","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0320","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1192\/bjp.bp.105.013045","article-title":"Mood switch in bipolar depression: Comparison of adjunctive venlafaxine, bupropion and sertraline","volume":"189","author":"Post","year":"2006","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0325","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.brainresrev.2009.06.003","article-title":"Bipolar disorder and mechanisms of action of mood stabilizers","volume":"61","author":"Rapoport","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0330","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa064135","article-title":"Effectiveness of adjunctive antidepressant treatment for bipolar depression","volume":"356","author":"Sachs","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0335","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopsych.2004.04.004","article-title":"Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the national institute of mental health genetics initiative pedigrees","volume":"56","author":"Schulze","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0340","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/mp.2008.134","article-title":"Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder","volume":"14","author":"Schulze","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0345","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.1073\/pnas.0813386106","article-title":"Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry","volume":"106","author":"Scott","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0350","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/sj.mp.4002151","article-title":"Whole-genome association study of bipolar disorder","volume":"13","author":"Sklar","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0355","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/mp.2009.43","article-title":"Genome-wide association study of bipolar disorder in European American and African American individuals","volume":"14","author":"Smith","year":"2009","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0360","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cell.2004.09.011","article-title":"CaV1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism","volume":"119","author":"Splawski","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0365","doi-asserted-by":"crossref","DOI":"10.4061\/2010\/159761","article-title":"Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder","author":"Squassina","year":"2010","journal-title":"Human Genomics Proteomics"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0370","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/mp.2009.149","article-title":"Expanding the range of ZNF804A variants conferring risk of psychosis","volume":"16","author":"Steinberg","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0375","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.mp.4001585","article-title":"The functional neuroanatomy of bipolar disorder: A review of neuroimaging findings","volume":"10","author":"Strakowski","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0380","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1042\/BST0340903","article-title":"Role of voltage-gated L-type Ca2+ channel isoforms for brain function","volume":"34","author":"Striessnig","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0385","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1017\/S0033291710002217","article-title":"Effects of a CACNA1C genotype on attention networks in healthy individuals","volume":"41","author":"Thimm","year":"2011","journal-title":"Psychol Med"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0390","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"10.1016\/j.pharmthera.2011.10.001_bb0395","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1038\/npp.2011.72","article-title":"The ZNF804A gene: Characterization of a novel neural risk mechanism for the major psychoses","volume":"36","author":"Voineskos","year":"2011","journal-title":"Neuropsychopharmacology,"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0400","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.schres.2010.09.002","article-title":"A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder","volume":"124","author":"Wang","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0405","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrg1406","article-title":"Thalassaemia: The long road from bedside to genome","volume":"5","author":"Weatherall","year":"2004","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0410","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/mp.2009.103","article-title":"The CACNA1C risk variant for bipolar disorder influences limbic activity","volume":"15","author":"Wessa","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0415","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/mp.2010.36","article-title":"Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder","volume":"16","author":"Williams","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2011.10.001_bb0420","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.biopsych.2011.01.003","article-title":"Evidence of sex-modulated association of ZNF804A with schizophrenia","volume":"69","author":"Zhang","year":"2011","journal-title":"Biol Psychiatry"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725811001860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725811001860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T19:21:21Z","timestamp":1713036081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725811001860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0163725811001860"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2011.10.001","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}